| The~ 53 proto-oncogene can act as a suppressor of transformation AJ Levine Cell 57 (7), 1083-1093, 1989 | 2980 | 1989 |
| Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life CA Finlay, PW Hinds, TH Tan, D Eliyahu, M Oren, AJ Levine Molecular and cellular biology, 1988 | 1488 | 1988 |
| Regulation of retinoblastoma protein functions by ectopic expression of human cyclins PW Hinds, S Mittnacht, V Dulic, A Arnold, SI Reed, RA Weinberg Cell 70 (6), 993-1006, 1992 | 1343 | 1992 |
| Physical interaction of the retinoblastoma protein with human D cyclins SF Dowdy, PW Hinds, K Louie, SI Reed, A Arnold, RA Weinberg Cell 73 (3), 499-511, 1993 | 1054 | 1993 |
| Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation P Hinds, C Finlay, AJ Levine Journal of virology 63 (2), 739-746, 1989 | 848 | 1989 |
| Cyclins and cdks in development and cancer: a perspective A Deshpande, P Sicinski, PW Hinds Oncogene 24 (17), 2909-2915, 2005 | 650 | 2005 |
| A common polymorphism acts as an intragenic modifier of mutant p53 behaviour MC Marin, CA Jost, LA Brooks, MS Irwin, J O'Nions, JA Tidy, N James, ... Nature genetics 25 (1), 47-54, 2000 | 643 | 2000 |
| Function of a human cyclin gene as an oncogene. PW Hinds, SF Dowdy, EN Eaton, A Arnold, RA Weinberg Proceedings of the National Academy of Sciences 91 (2), 709-713, 1994 | 631 | 1994 |
| Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the “hot spot” mutant phenotypes PW Hinds, CA Finlay, RS Quartin, SJ Baker, ER Fearon, B Vogelstein, ... Cell Growth Differ 1 (12), 571-580, 1990 | 563 | 1990 |
| Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4 E Neuman, MH Ladha, N Lin, TM Upton, SJ Miller, J DiRenzo, RG Pestell, ... Molecular and cellular biology 17 (9), 5338-5347, 1997 | 501 | 1997 |
| The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation DM Thomas, SA Carty, DM Piscopo, JS Lee, WF Wang, WC Forrester, ... Molecular cell 8 (2), 303-316, 2001 | 439 | 2001 |
| Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis MW Landis, BS Pawlyk, T Li, P Sicinski, PW Hinds Cancer cell 9 (1), 13-22, 2006 | 395 | 2006 |
| Tumor suppressor genes PW Hinds, RA Weinberg Current opinion in genetics & development 4 (1), 135-141, 1994 | 355 | 1994 |
| PTEN expression in non–small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration CJ Marsit, S Zheng, K Aldape, PW Hinds, HH Nelson, JK Wiencke, ... Human pathology 36 (7), 768-776, 2005 | 322 | 2005 |
| Proliferation of functional hair cells in vivo in the absence of the retinoblastoma protein C Sage, M Huang, K Karimi, G Gutierrez, MA Vollrath, DS Zhang, ... Science 307 (5712), 1114-1118, 2005 | 311 | 2005 |
| Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p53-plus-ras-transformed cell lines PW Hinds, CA Finlay, AB Frey, AJ Levine Molecular and cellular biology, 1987 | 309 | 1987 |
| The retinoblastoma protein and the regulation of cell cycling D Cobrinik, SF Dowdy, PW Hinds, S Mittnacht, RA Weinberg Trends in biochemical sciences 17 (8), 312-315, 1992 | 291 | 1992 |
| Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma DM Thomas, SA Johnson, NA Sims, MK Trivett, JL Slavin, BP Rubin, ... The Journal of cell biology 167 (5), 925-934, 2004 | 253 | 2004 |
| P53 is a tumor suppressor gene AJ Levine, CA Finlay, PW Hinds Cell 116, S67-S70, 2004 | 232 | 2004 |
| A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25A X Zhang, I Neganova, S Przyborski, C Yang, M Cooke, SP Atkinson, ... The Journal of cell biology 184 (1), 67-82, 2009 | 225 | 2009 |
Karl MungerTufts University School of MedicineVerified email at tufts.edu
